Thomas Shrader Analyst PerformanceEquity Research Analyst at BTIG ResearchThomas Shrader is a stock analyst at BTIG Research, covering 27 publicly traded companies across a range of sectors. Over the past year, Thomas Shrader has issued 11 stock ratings, including buy and hold recommendations. While full access to Thomas Shrader's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Thomas Shrader's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Ratings, Coverage, and Performance StatisticsAnalyst RatingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings69 Last 10 YearsBuy Recommendations86.96% 60 Buy RatingsCompanies Covered27 Unique Companies Ratings Distribution69RatingsDistribution of strong buy, buy, hold, and sell ratings by Thomas Shrader.RatingPercentageCount Strong Buy0.0%0 ratings Buy87.0%60 ratings Hold13.0%9 ratings Sell0.0%0 ratingsOut of 69 total stock ratings issued by Thomas Shrader at BTIG Research, the majority (87.0%) have been Buy recommendations, followed by 13.0% Hold.Best & Worst CallsBest Call0000.0%CLVSJun 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ESPRJul 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ96.3% of companies on NASDAQ26 companiesNYSE3.7% of companies on NYSE1 companyThomas Shrader, an analyst at BTIG Research, currently covers 27 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical25 companies92.6%Miscellaneous2 companies7.4%Thomas Shrader of BTIG Research specializes in stock coverage within the Medical sector, with additional focus on companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE14 companies51.9%MED - DRUGS5 companies18.5%PHARMACEUTICAL PREPARATIONS3 companies11.1%BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC2 companies7.4%Miscellaneous2 companies7.4%BIOTECHNOLOGY1 company3.7% About Thomas ShraderThomas Shrader, PhD, CFA, is a Managing Director and Healthcare Analyst at BTIG. He provides coverage of the biotechnology sector, with a focus on large and smidcap companies. Previously, he was a Biotechnology Research Analyst at Stifel. Earlier in his career, Mr. Shrader was on the Biochemistry Faculty at the Albert Einstein College of Medicine. He earned a BA from The Johns Hopkins University, a PhD from Yale University and was a Helen Hay Whitney Fellow at the Massachusetts Institute of Technology.Follow on LinkedIn Thomas Shrader's Ratings History at BTIG Research Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export to Excel CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsDRUGBright Minds Biosciences9/8/2025Initiated Coverage$42.24$72.00Buy$0.0000.00% ROIGANXGain Therapeutics9/8/2025Reiterated Rating$1.76$9.00Buy$0.0000.00% ROIACIUAC Immune9/8/2025Reiterated Rating$2.28$8.00Buy$0.0000.00% ROIBHVNBiohaven8/19/2025Boost Price Target$15.71$60.00Buy$0.0000.00% ROISTOKStoke Therapeutics8/18/2025Set Price Target$18.26$28.00Buy$0.0000.00% ROIHROWHarrow8/14/2025Boost Price Target$36.50$63.00Buy$0.0000.00% ROIVRNAVerona Pharma PLC American Depositary Share7/10/2025Downgrade$104.77Hold$0.0000.00% ROIINMBINmune Bio7/1/2025Reiterated Rating$2.31Neutral$0.0000.00% ROIALDXAldeyra Therapeutics4/7/2025Lower Price Target$1.76$9.00Buy$0.0000.00% ROIOVIDOvid Therapeutics3/24/2025Lower Price Target$0.44$4.00Buy$0.0000.00% ROIARCTArcturus Therapeutics1/28/2025Initiated Coverage$16.43$41.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
